This inventor holds 2 USPTO granted patents. Top assignee: Sri International. Active years: 1992-1993.
Company Filing History:
Years Active: 1992-1993
Title: Richard C. Winant: Innovator in Protein Purification and Anticoagulant Research
Introduction
Richard C. Winant is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of biochemistry, particularly in the purification of proteins and the development of anticoagulant agents. With a total of 2 patents, Winant's work has had a meaningful impact on medical research and applications.
Latest Patents
Winant's latest patents include innovative processes and compounds. One of his patents, titled "Purification of proteins employing CTAP-III fusions," provides a method for recovering heterologous proteins from CTAP-III fusion proteins. This process involves expressing a fusion protein with specific amino acid sequences and cleaving it to obtain distinct polypeptide fragments, which are then separated by ion exchange chromatography. Another significant patent is for "Analogs of hirudin," which includes compounds and compositions of amino acid-substituted and chemically modified analogs of hirudin. These analogs are designed for use as antithrombotic and anticoagulant agents, showcasing Winant's focus on advancing therapeutic solutions.
Career Highlights
Richard C. Winant is associated with SRI International, a renowned research institution. His work at SRI has allowed him to explore various innovative approaches in biochemistry and contribute to advancements in medical science. His expertise and dedication have positioned him as a key figure in his field.
Collaborations
Winant has collaborated with esteemed colleagues such as Paul H. Johnson and Jerome B. Lazar. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.
Conclusion
Richard C. Winant's contributions to protein purification and anticoagulant research highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving therapeutic options.